المحتوى المفصّل متاح بالإنجليزية حالياً.

• 01MOH KSA license to Practice, 2023

المحتوى المفصّل متاح بالإنجليزية حالياً.

• 01A phase II study of cisplatin as radiosensitizer during standard radiotherapy for high grade gliomas, followed by lomustine based chemotherapy. Abdel Karim k., Lotfy A., Refae A., Elhusseiny K., Soud K. The Egyptian Journal of Neurosurgery, Jun, 2006.
• 02Brain metastases in breast cancer patients; one week versus two weeks whole brain radiotherapy; prognostic factors assessment. Refae A., Sharaf OM., Awad M., Saoud K. The Egyptian Journal of Neurosurgery, Jan 2008.
• 03Gemcitabine with oxaliplatin(GEMOX)in metastatic carcinoma of unknown primary (CUP). Refae AA., Fouad IM., Abdel Karim KM., Farag AL., Elhusseiny KN. Kasr Al Aini Medical Journal , jun., 2007.
• 04Induction cisplatin and weekly paclitaxel followed by radiotherapy and concurrent weekly cisplatin in loco-regionally advanced nasopharyngeal carcinoma. Refae AA., El-Kady MS., Farag AL., El-Ghazaly HA., Abdel karim NN., Sharaf OM., Shehata M. Scientific Journal of al-Azhar Medical College girls.2007.
• 05One year low dose oral etoposide as maintenance therapy in patients With advanced ovarian carcinoma after clinical complete response to platinum and paclitaxel chemotherapy. El-husseiny K., Refae A., Farag AL., Elghazaly H., Alebeisy H Scientific Journal of al-Azhar Medical College girls. Jan 2008.

المحتوى المفصّل متاح بالإنجليزية حالياً.